Literature DB >> 34063960

Antiretroviral Therapy Improves Acquired Immunodeficiency Syndrome with Systemic Lupus Erythematosus.

Akinori Okada1, Yuji Nozaki1, Shinya Rai1, Koji Kinoshita1, Masanori Funauchi1, Itaru Matsumura1.   

Abstract

A 35-year-old male was referred to our hospital with dysesthesia of the lower extremities that had begun six months earlier. A blood test revealed the presence of various antibodies, suggesting a collagen-related peripheral neuropathy. However, a history of repeated shingles and sex with males was noted, and the patient was tested for and diagnosed with human immunodeficiency virus (HIV) infection. Based on the manifestations and laboratory data, including the results of immunological and urinary tests, he was further diagnosed with concomitant systemic lupus erythematosus (SLE). The activity of SLE improved with antiretroviral therapy. There is currently no established treatment for AIDS complicated with SLE. Indeed, because HIV treatment involves the activation of immune function and SLE treatment involves immunosuppression, any treatments for the two conditions would be in conflict. It is thus necessary to select a treatment strategy based on the condition of the individual patient. In addition, because HIV infection is relatively rare in Japan compared to other countries, rheumatologists in Japan must keep HIV infection in mind as a differential diagnosis for autoimmune diseases.

Entities:  

Keywords:  acquired immunodeficiency syndrome; antiretroviral therapy; autoimmune disease; human immunodeficiency virus; systemic lupus erythematosus

Year:  2021        PMID: 34063960     DOI: 10.3390/life11060463

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  21 in total

1.  Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

Authors:  M Scherl; U Posch; G Obermoser; C Ammann; N Sepp; H Ulmer; M P Dierich; H Stoiber; B Falkensammer
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 2.  HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment.

Authors:  Avi Z Rosenberg; Saraladevi Naicker; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2015-02-17       Impact factor: 28.314

3.  Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia.

Authors:  Aristotelis Tsiakalos; John G Routsias; Theodore Kordossis; Haralampos M Moutsopoulos; Athanasios G Tzioufas; Nikolaos V Sipsas
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

Review 4.  Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge.

Authors:  Simona Gindea; Julie Schwartzman; Leal C Herlitz; Michael Rosenberg; Jacobo Abadi; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2010-02-04       Impact factor: 5.532

5.  Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients.

Authors:  S Muller; P Richalet; A Laurent-Crawford; S Barakat; Y Rivière; F Porrot; S Chamaret; J P Briand; L Montagnier; A Hovanessian
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

Review 6.  False-positive human immunodeficiency virus testing in patients with lupus erythematosus.

Authors:  H R Barthel; D J Wallace
Journal:  Semin Arthritis Rheum       Date:  1993-08       Impact factor: 5.532

Review 7.  Autoimmune diseases in HIV-infected patients: 52 cases and literature review.

Authors:  Laura Iordache; Odile Launay; Olivier Bouchaud; Vincent Jeantils; Cécile Goujard; Francois Boue; Patrice Cacoub; Thomas Hanslik; Alfred Mahr; Olivier Lambotte; Olivier Fain
Journal:  Autoimmun Rev       Date:  2014-04-18       Impact factor: 9.754

8.  Association of human immunodeficiency virus infection and autoimmune phenomena.

Authors:  R G Kopelman; S Zolla-Pazner
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

Review 9.  HIV infection and its effects on the development of autoimmune disorders.

Authors:  Luis E Vega; Luis R Espinoza
Journal:  Pharmacol Res       Date:  2018-01-10       Impact factor: 7.658

10.  Systemic lupus erythematosus in HIV: An insight into clinical implications and management.

Authors:  Vasudha A Belgaumkar; Ravindranath B Chavan; Prernaa R Suryataley; Aarti S Salunke; Pallavi P Patil; Sandhya M Borade
Journal:  Indian J Sex Transm Dis AIDS       Date:  2019 Jan-Jun
View more
  1 in total

Review 1.  HIV-Associated Systemic Sclerosis: Literature Review and a Rare Case Report.

Authors:  Shamimul Hasan; Mohd Aqil; Rajat Panigrahi
Journal:  Int J Environ Res Public Health       Date:  2022-08-15       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.